대한한방내과학회지 (The Journal of Internal Korean Medicine)

대한한방내과학회 (The Society of Internal Korean Medicine)
권호 표지
DOI QR코드

DOI QR Code

약물 중단에도 지속되는 약인성 파킨슨증후군 환자의 한의 치험 1례

A Case Report of Persistent Drug-Induced Parkinsonism After Drug Discontinuation

  • 최정우 (강동경희대학교병원 뇌신경센터 한방내과) ;
  • 김서영 (경희대학교 대학원 한방순환신경내과학교실) ;
  • 전규리 (경희대학교 대학원 한방순환신경내과학교실) ;
  • 황예채 (경희대학교 대학원 한방순환신경내과학교실) ;
  • 조승연 (강동경희대학교병원 뇌신경센터 한방내과) ;
  • 박정미 (강동경희대학교병원 뇌신경센터 한방내과) ;
  • 고창남 (강동경희대학교병원 뇌신경센터 한방내과) ;
  • 박성욱 (강동경희대학교병원 뇌신경센터 한방내과)
  • Choi, Jeong-woo (Stroke and Neurological Disorders Center, Kyung Hee University Hospital at Gangdong) ;
  • Kim, Seo-young (Dept. of Cardiology and Neurology of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Jun, Gyu-ri (Dept. of Cardiology and Neurology of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Hwang, Ye-chae (Dept. of Cardiology and Neurology of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Cho, Seung-yeon (Stroke and Neurological Disorders Center, Kyung Hee University Hospital at Gangdong) ;
  • Park, Jung-mi (Stroke and Neurological Disorders Center, Kyung Hee University Hospital at Gangdong) ;
  • Ko, Chang-nam (Stroke and Neurological Disorders Center, Kyung Hee University Hospital at Gangdong) ;
  • Park, Seong-uk (Stroke and Neurological Disorders Center, Kyung Hee University Hospital at Gangdong)
  • 투고 : 2021.11.30
  • 심사 : 2021.12.30
  • 발행 : 2021.12.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

This study examined the effectiveness of Korean medical treatment in a patient with persistent drug-induced parkinsonism after drug discontinuation. The changes in symptoms were assessed using the unified parkinson's disease rating scale (UPDRS), postural instability-gait disturbance (PIGD) score, and the 20 m gait time and steps. After 22 days of hospitalization, the UPDRS, PIGD score, and 20 m gait time and steps showed clinically significant improvement. The improvement persisted after discharge. This study indicated that Korean medical treatment could be an effective alternative therapy for treating persistent drug-induced parkinsonism after drug discontinuation.

키워드

참고문헌

  1. Miller LG, Jankovic J. Neurologic approach to drug-induced movement disorders: a study of 125 patients. South Med J 1990;83(5):525-32. https://doi.org/10.1097/00007611-199005000-00011
  2. Hassin-Baer S, Sirota P, Korczyn AD, Treves TA, Epstein B, Shabtai H, et al. Clinical characteristics of neuroleptic-induced parkinsonism. J Neural Transm 2001;108(11):1299-308. https://doi.org/10.1007/s007020100006
  3. Barbosa MT, Caramelli P, Maia DP, Cunningham MC, Guerra HL, Lima-Costa MF, et al. Parkinsonism and Parkinson's disease in the elderly: a community-based survey in Brazil. Mov Disord 2006;21(6):800-8. https://doi.org/10.1002/mds.20806
  4. Poewe W, Scherfler C. Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice. Mov Disord 2003;18 Suppl 7:S16-S21. https://doi.org/10.1002/mds.10573
  5. Tinazzi M, Cipriani A, Matinella A, Cannas A, Solla P, Nicoletti A, et al. [123I]FP- CIT single photon emission computed tomography findings in drug-induced parkinsonism. Schizophr Res 2012;139(1-3):40-5. https://doi.org/10.1016/j.schres.2012.06.003
  6. Lee PH, Yeo SH, Yong SW, Yun JK. Odour identification test and its relation to cardiac 123I-metaiodobenzylguanidine in patients with drug induced parkinsonism. J Neurol Neurosurg Psychiatry 2007;78(11):1250-2. https://doi.org/10.1136/jnnp.2007.121285
  7. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 1999;52(6):1214-20. https://doi.org/10.1212/WNL.52.6.1214
  8. Jung SK, Song JM. Two Cases of Drug-induced Secondary Parkinsonism Treated with Sasang. Constitutional Therapy. J Sasang Constitut Med 2012;24(4):109-19. https://doi.org/10.7730/JSCM.2012.24.4.109
  9. Kim H, Kim GW, Koo BS. Clinical study on a case of a patient with a glossal tremor caused by a side effect of drugs. J Orient Neuropsychiatry 2003;14(1):133-9.
  10. Kim EJ, Song HJ, Kim HH, Han YH, Leem JT. A Case Report of Drug-Induced Parkinsonism Treated with Jodeung-san and Electro-acupuncture at GB34. J Int Korean Med 2017;38(5):600-9. https://doi.org/10.22246/jikm.2017.38.5.600
  11. Kim YJ, Yang SB, Kim JH, Lee BY, Cho SY, Park SU, et al. Case of Drug-Induced Parkinsonism Treated with Traditional Korean Medicine. J Int Korean Med 2016;37(2):381-8.
  12. Lee SH, Shin HY, Kim JH, Kim YJ, Cho SY, Park JM, et al. A Case of Drug-Induced Acute Dyskinesia Treated with Korean Medicine. J Int Korean Med 2017;38(5):853-61. https://doi.org/10.22246/jikm.2017.38.5.853
  13. 박성욱. 약침의 정석 : 통증편. 1판. 서울: 우리의학서적; 2020, p. 44, 58-60, 88, 95-8, 127-37, 153-6, 182-4.
  14. Ramaker C, Marinus J, Stiggelbout AM, van Hilten BJ. Systematic evaluation of rating scales for impairment and disability in Parkinson's disease. Movement Disorders 1 September 2002;17(5):867-76. https://doi.org/10.1002/mds.10248
  15. Jankovic JM, Dermott MJ, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. Neurology 1990;40(10):1529-34. https://doi.org/10.1212/WNL.40.10.1529
  16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth ed. Arlington, VA: American Psychiatric Association; 2013.
  17. Jimeez-Jimeez FJ, OrtiPareja M, Ayuso-Peralta L, Gasalla T, Cabrera-Valdivia F, Vaquero A, et al. Drug-induced parkinsonism in a movement disorders unit: a four-year survey. Parkinsonism Relat Disord 1996;2(3):145-49. https://doi.org/10.1016/1353-8020(96)00013-2
  18. Kenney C, Hunter C, Davidson A, Jankovic J. Metoclopramide, an increasingly recognized cause of tardive dyskinesia. J Clin Pharmacol 2008; 48(3):379-84. https://doi.org/10.1177/0091270007312258
  19. Blanchet P, Kivenko V. Drug-induced parkinsonism: diagnosis and management. Journal of parkinsonism and restless legs syndrome 23 September 2016;2016:83-91. https://doi.org/10.2147/JPRLS.S99197
  20. Sethi KD. Movement disorders induced by dopamine blocking agents. Semin Neurol 2001;21(1):59-68. https://doi.org/10.1055/s-2001-13120
  21. Tolosa E, Coelho M, Gallardo M. DAT imaging in drug-induced and psychogenic parkinsonism. Mov Disord 2003;18 Suppl 7:28-33. https://doi.org/10.1002/mds.10560
  22. DA van de Vijver. Influence of benzodiazepines on antiparkinsonian drug treatment in levodopa users. Acta Neurol Scand 2002 Jan;105(1):8-12. https://doi.org/10.1034/j.1600-0404.2002.00132.x
  23. Lisa MS, Ann LG, Karen EA, Paul SF, Stephen GR, William JW. The clinically important difference on the unified Parkinson's disease rating scale. Arch Neurol 2010 Jan;67(1):64-70. https://doi.org/10.1001/archneurol.2009.295
  24. Baek H, Jang HI, Jeon HN, Bae H. Comparison of Administration Routes on the Protective Effects of Bee Venom Phospholipase A2 in a Mouse Model of Parkinson's Disease. Frontiers in Aging Neuroscience 2018;10:179. https://doi.org/10.3389/fnagi.2018.00179
  25. Cho SY, Lee YE, Doo KH, Lee JH, Jung WS, Moon SK, et al. Efficacy of Combined Treatment with Acupuncture and Bee Venom Acupuncture as an Adjunctive Treatment for Parkinson's Disease. J Altern Complement 2018 Jan;24(1):25-32. https://doi.org/10.1089/acm.2016.0250
  26. Kim HR, Jeong HS, Shin HY, Choi JW, Yang SB, Cho SY, et al. A Case of Korean Medical Treatment on Parkinson's Disease Patient with Postural Instability, Presenting as Camptocormia. J Int Korean Med 2019;40(2):220-7. https://doi.org/10.22246/jikm.2019.40.2.220
  27. Park YG, Lee MS, Kim SH, Bae NY. Long-term Clinical Efficacy on Three Soyang Patients with Parkinson's Disease Improved by Combined Treatment of Korean-Western Medicine. J Sasang Constitut Med 2016;28(4):361-71. https://doi.org/10.7730/JSCM.2016.28.4.361
  28. Park YG, Lee MS, Bae NY. Case Study of Soyang Patient with Parkinson Disease Having Depression. J Sasang Constitut Med 2015;27(3):356-65. https://doi.org/10.7730/JSCM.2015.27.3.356
  29. Kim SN, Doo AR, Park JY, Bae H, Chae Y, Shim I, et al. Acupuncture enhances the synaptic dopamine availability to improve motor function in a mouse model of Parkinson's disease. PLoS One 2011;6(11):e27566. https://doi.org/10.1371/journal.pone.0027566